FGF signaling in the developing endochondral skeleton
- PMID: 15863035
- PMCID: PMC3083241
- DOI: 10.1016/j.cytogfr.2005.02.003
FGF signaling in the developing endochondral skeleton
Abstract
Mutations in fibroblast growth factor receptors (Fgfrs) are the etiology of many craniosynostosis and chondrodysplasia syndromes in humans. The phenotypes associated with these human syndromes and the phenotypes resulting from targeted mutagenesis in the mouse have defined essential roles for FGF signaling in both endochondral and intramembranous bone development. In this review, I will focus on the role of FGF signaling in chondrocytes and osteoblasts and how FGFs regulate the growth and development of endochondral bone.
Figures
Similar articles
-
Recent research on the growth plate: Advances in fibroblast growth factor signaling in growth plate development and disorders.J Mol Endocrinol. 2014 Aug;53(1):T11-34. doi: 10.1530/JME-14-0012. J Mol Endocrinol. 2014. PMID: 25114206 Review.
-
FGF signaling in skeletal development.Front Biosci. 1998 Aug 1;3:d781-94. doi: 10.2741/a321. Front Biosci. 1998. PMID: 9683641 Review.
-
FGFs in endochondral skeletal development.J Cell Biochem. 2010 Aug 1;110(5):1046-57. doi: 10.1002/jcb.22629. J Cell Biochem. 2010. PMID: 20564212
-
Fibroblast growth factors in skeletal development.Curr Top Dev Biol. 2019;133:195-234. doi: 10.1016/bs.ctdb.2018.11.020. Epub 2019 Jan 3. Curr Top Dev Biol. 2019. PMID: 30902253 Review.
-
Role of FGFs/FGFRs in skeletal development and bone regeneration.J Cell Physiol. 2012 Dec;227(12):3731-43. doi: 10.1002/jcp.24083. J Cell Physiol. 2012. PMID: 22378383 Review.
Cited by
-
Mutations in fibroblast growth factor (FGF8) and FGF10 identified in patients with conotruncal defects.J Transl Med. 2020 Jul 14;18(1):283. doi: 10.1186/s12967-020-02445-2. J Transl Med. 2020. PMID: 32664970 Free PMC article.
-
Fibroblast Growth Factor Ligand Dependent Proliferation and Chondrogenic Differentiation of Synovium-Derived Stem Cells and Concomitant Adaptation of Wnt/Mitogen-Activated Protein Kinase Signals.Tissue Eng Part A. 2016 Aug;22(15-16):1036-46. doi: 10.1089/ten.TEA.2016.0102. Tissue Eng Part A. 2016. PMID: 27411850 Free PMC article.
-
Cell type-specific control of protein synthesis and proliferation by FGF-dependent signaling to the translation repressor 4E-BP.Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7545-50. doi: 10.1073/pnas.1605451113. Epub 2016 Jun 16. Proc Natl Acad Sci U S A. 2016. PMID: 27313212 Free PMC article.
-
barx1 is necessary for ectomesenchyme proliferation and osteochondroprogenitor condensation in the zebrafish pharyngeal arches.Dev Biol. 2008 Sep 1;321(1):101-10. doi: 10.1016/j.ydbio.2008.06.004. Epub 2008 Jun 13. Dev Biol. 2008. PMID: 18590717 Free PMC article.
-
Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia.PLoS One. 2018 Apr 13;13(4):e0195876. doi: 10.1371/journal.pone.0195876. eCollection 2018. PLoS One. 2018. PMID: 29652901 Free PMC article.
References
-
- Horton WA, Lunstrum GP. Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism. Rev Endocr Metab Disord. 2002;3:381–5. - PubMed
-
- Ikegawa S, Fukushima Y, Isomura M, Takada F, Nakamura Y. Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients. Hum Genet. 1995;96:309–11. - PubMed
-
- Rousseau F, Bonaventure J, Legeal-Mallet L, Pelet A, Rozet J-M, Maroteaux P, et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 1994;371:252–4. - PubMed
-
- Shiang R, Thompson LM, Zhu Y-Z, Church DM, Fielder TJ, Bocian M, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 1994;78:335–42. - PubMed
-
- Superti-Furga A, Eich G, Bucher HU, Wisser J, Giedion A, Gitzelmann R, et al. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur J Pediatr. 1995;154:215–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources